Predictors of pulmonary hypertension in the subacute period of myocardial infarction in young and middle-aged males
https://doi.org/10.20538/1682-0363-2024-4-74-81
Abstract
Aim. To identify predictors of the development of pulmonary hypertension (PH) in the subacute period of myocardial infarction (MI) in young and middle-aged males to improve preventive measures.
Materials and methods. We studied the results of treatment of male patients aged 32–60 years with a verified diagnosis of MI. Based on echocardiography findings and detection of PH at the end of the third week of MI, the patients were divided into the study group (patients with PH) and the comparison group (patients with a normal pressure in the pulmonary artery). In the studied groups, a comparative assessment of various parameters was performed, and an analysis of the risks of developing PH using the Pearson’s chi-squared test was conducted.
Results. We found that the risk of developing PH in the subacute period of MI was significantly affected by certain parameters of peripheral hemodynamics, the presence of bradycardia, and the calculated value of total pulmonary resistance. The main parameters of the lipid profile were found to be significant predictors of PH in the subacute period of MI, along with some parameters of electrolyte metabolism (sodium and magnesium in the first 48 hours of MI, potassium and calcium at the end of the third week of the disease). We established the presence of a reliable relationship between several parameters of the structural and functional state of the myocardium both in the first 48 hours of MI and the end of the third week of the disease with the risk of developing PH in the subacute period of MI.
Conclusion. The identified predictors make it possible to determine patients with MI who are at an increased risk of PH to timely diagnose and treat the disease and improve the prognosis.
About the Authors
A. N. Menshikova
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
6, Akademika Lebedeva Str., Saint Petersburg, 194044
A. V. Gordienko
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
6, Akademika Lebedeva Str., Saint Petersburg, 194044
A. V. Sotnikov
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
6, Akademika Lebedeva Str., Saint Petersburg, 194044
D. V. Nosovich
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
6, Akademika Lebedeva Str., Saint Petersburg, 194044
References
1. Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M. et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2023;61(1):2200879. DOI: 10.1183/13993003.00879-2022.
2. Maeder M.T., Schoch O.D., Kleiner R., Joerg L., Weilenmann D., Swiss Society For Pulmonary Hypertension. Pulmonary hypertension associated with left-sided heart disease. Swiss Med. Wkly. 2017;147:w14395. DOI: 10.4414/smw.2017.14395.
3. Çetin M., Özer S., Çinier G., Yılmaz A.S., Erdoğan T., Şatıroğlu Ö. Left atrial volume index and pulmonary arterial pressure predicted MACE among patients with STEMI during 8-year follow-up: experience from a tertiary center. Herz. 2021;46(4):367–374. DOI: 10.1007/s00059-020-04966-4.
4. Sannino A., Smith R.L., Schiattarella G.G., Trimarco B., Esposito G., Grayburn P.A. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol. 2017;2(10):1130– 1139. DOI: 10.1001/jamacardio.2017.2976.
5. Fan X.T., Wang S.J., Mujahid H., Ji X.P. Effect of elevated pulmonary artery systolic pressure on short-term prognosis in patients with acute myocardial infarction. Angiology. 2020;71(6):567–572. DOI: 10.1177/0003319720909056.
6. Benjamin E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S. et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67–e492. DOI: 10.1161/CIR.0000000000000558.
7. Бойцов С.А., Погосова Н.В., Бубнова М.Г., Драпкина О.М., Гаврилова Н.Е., Еганян Р.А. и др. Кардиоваскулярная профилактика 2017. Национальные рекомендации. Российский кардиологический журнал. 2018;23(6):7–122. DOI: 10.15829/1560-4071-2018-6-7-122.
8. Chung K., Strange G., Codde J., Celermajer D., Scalia G.M., Playford D. Left heart disease and pulmonary hypertension: are we seeing the full picture? Heart Lung Circ. 2018;27(3):301– 309. DOI: 10.1016/j.hlc.2017.09.015.
9. Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A. et al. Fourth universal definition of myocardial infarction (2018). Eur. Heart J. 2019;40(3):237–269. DOI: 10.1093/eurheartj/ehy462.
10. Kitabatake A., Iuone M., Asao M. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation.1983;68(2):302–309. DOI: 10.1161/01.cir.68.2.302.
11. Вдовенко Д.В., Либов И.А., Либис Р.А. Тканевая допплерография и speckle-tracking эхокардиография в оценке функционального состояния миокарда левых отделов сердца у больных с хронической сердечной недостаточностью и сохраненной фракцией выброса. Кардиология. 2019;59(2):17–23. DOI:10.18087/cardio.2019.2.10227.
12. Galderisi M., Cosyns B., Edvardsen T., Cardim N., Delgado V., Di Salvo G. et al. 2016–2018 EACVI Scientific Documents Committee. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imag. 2017;18(12):1301–1310. DOI: 10.1093/ehjci/jex244.
13. Бартош-Зеленая С.Ю., Гусева О.А. Алгоритм проведения эхокардиографии и формирование заключения. СПб.: СПбГПУ, 2014:65.
14. Сотников А.В., Гордиенко А.В., Носович Д.В., Яковлев В.В., Егоренкова Е.В., Ковалев С.В. Неинвазивная оценка влияния клинических параметров на гемодинамику малого круга кровообращения у мужчин моложе 60 лет с инфарктом миокарда в начальные периоды заболевания. Евразийский кардиологический журнал. 2017;3:85.
15. Гордиенко А.В., Сотников А.В., Носович Д.В. Клинические критерии оценки качества жизни у мужчин молодого и среднего возраста в начальные периоды инфаркта миокарда. Медико-фармацевтический журнал «Пульс». 2018;20(1):34–44.
16. Sidhu S., Marine J.E. Evaluating and managing bradycardia. Trends in Cardiovascular Medicine. 2020;30(5):265–272. DOI: 10.1016/j.tcm.2019.07.001.
17. Yao X., Gordon E.M., Figueroa D.M., Barochia A.V., Levine S.J. Emerging roles of apolipoprotein E and apolipoprotein A-I in the pathogenesis and treatment of lung disease. Am. J. Respir. Cell Mol. Biol. 2016;55(2):159–169. DOI: 10.1165/rcmb.2016-0060TR.
18. Song Z., Gao R., Yan B. Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease. Rev. Cardiovasc. Med. 2020;21(1):57–64. DOI: 10.31083/j.rcm.2020.01.577.
19. Boratkó A., Csortos C. PKC mediated phosphorylation of TIMAP regulates PP1c activity and endothelial barrier function. Biochimica et Biophysica acta. Molecular Cell Research. 2017;1864(2):431–439. DOI: 10.1016/j.bbamcr.2016.12.001.
20. Yuan Y., Du W., Liu J., Ma W., Zhang L., Du Z., Cai B. Stem cell-derived exosome in cardiovascular diseases: macro roles of micro particles. Front. Pharmacol. 2018;9:547. DOI: 10.3389/fphar.2018.00547.
21. Liu G,. Fu D., Tian H., Dai A. The mechanism of ions in pulmonary hypertension. Pulm. Circ. 2021;11(1):1–20. DOI: 10.1177/2045894020987948.
22. Da Costa Junior A.A., Ota-Arakaki J.S., Ramos R.P., Uellendahl M., Mancuso F.J., Gil M.A. et al. Diagnostic and prognostic value of right ventricular strain in patients with pulmonary arterial hypertension and relatively preserved functional capacity studied with echocardiography and magnetic resonance. Int. J. Cardiovasc. Imag. 2017;33(1):39–46. DOI: 10.1007/s10554-016-0966-1.
23. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42(36):3599–3726. DOI: 10.1093/eurheartj/ehab368.
24. Kabbach G., Mukherjee D. Pulmonary hypertension secondary to left heart disease. Curr. Vasc. Pharmacol. 2018;16(6):555– 560. DOI: 10.2174/1570161115666170913105424.
25. Amorós-Figueras G., Roselló-Diez E., Sanchez-Quintana D., Casabella-Ramon S., Jorge E., Nevado-Medina J. et al. Changes in local atrial electrograms and surface ECG induced by acute atrial myocardial infarction. Front. Physiol. 2020;11:264. DOI: 10.3389/fphys.2020.00264.
Review
For citations:
Menshikova A.N., Gordienko A.V., Sotnikov A.V., Nosovich D.V. Predictors of pulmonary hypertension in the subacute period of myocardial infarction in young and middle-aged males. Bulletin of Siberian Medicine. 2024;23(4):74-81. https://doi.org/10.20538/1682-0363-2024-4-74-81
Views:
130
Email this article 